Xenon Pharmaceuticals (XENE) Share-based Compensation (2013 - 2026)
Xenon Pharmaceuticals (XENE) reported Share-based Compensation of $16.73 million for Q2 2026, up 22.0% from $13.71 million a year earlier but down 1.0% from the prior quarter.
Powered by 
Analysis
Xenon Pharmaceuticals (XENE) Share-based Compensation (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Xenon Pharmaceuticals' Share-based Compensation came in at $61.45 million, up 17.1% year-over-year; for FY2025, it came in at $53.71 million, up 5.9% from FY2024.
- Share-based Compensation has increased for nine consecutive years, with a five-year compound annual growth rate of 56.7% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $50.72 million in FY2024 (+56.7%), $32.37 million in FY2023 (+58.9%), $20.38 million in FY2022 (+103.4%) and $10.02 million in FY2021 (+76.4%).
- Five-year quarterly Share-based Compensation spans a low of $2.64 million in Q3 2021 and a high of $16.89 million in Q1 2026.
- Year over year, Share-based Compensation has now increased in each of the last four quarters, with growth averaging 23.7% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q3 2022 (growth of 117.3%); the low point was Q2 2025 (a decline of 6.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $16.89 million (Q1 2026), $14.12 million (Q4 2025) and $13.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Xenon Pharmaceuticals | 4.06 Bn | 1.03 Bn | - | 16.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.73 Mn |
| Mar 31, 2026 | 16.89 Mn |
| Dec 31, 2025 | 14.12 Mn |
| Sep 30, 2025 | 13.71 Mn |
| Jun 30, 2025 | 13.71 Mn |
| Mar 31, 2025 | 12.17 Mn |
| Dec 31, 2024 | 13.60 Mn |
| Sep 30, 2024 | 13.00 Mn |
| Jun 30, 2024 | 14.72 Mn |
| Mar 31, 2024 | 9.40 Mn |
| Dec 31, 2023 | 9.18 Mn |
| Sep 30, 2023 | 8.74 Mn |
| Jun 30, 2023 | 8.45 Mn |
| Mar 31, 2023 | 5.99 Mn |
| Dec 31, 2022 | 5.81 Mn |
| Sep 30, 2022 | 5.74 Mn |
| Jun 30, 2022 | 5.21 Mn |
| Mar 31, 2022 | 3.61 Mn |
| Dec 31, 2021 | 2.71 Mn |
| Sep 30, 2021 | 2.64 Mn |
API Access
Xenon Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=XENE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "XENE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=XENE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();